- Report
- March 2024
- 200 Pages
Global
From €3771EUR$4,150USD£3,241GBP
- Report
- March 2024
- 200 Pages
Global
From €3771EUR$4,150USD£3,241GBP
- Report
- March 2024
- 200 Pages
Global
From €3771EUR$4,150USD£3,241GBP
- Report
- March 2024
- 200 Pages
Global
From €3771EUR$4,150USD£3,241GBP
- Report
- January 2024
- 200 Pages
Global
From €3771EUR$4,150USD£3,241GBP
- Report
- January 2024
- 200 Pages
Global
From €3771EUR$4,150USD£3,241GBP
- Report
- January 2024
- 200 Pages
Global
From €3771EUR$4,150USD£3,241GBP
- Report
- January 2024
- 200 Pages
Global
From €3771EUR$4,150USD£3,241GBP
- Report
- July 2023
- 145 Pages
Global
From €2862EUR$3,150USD£2,460GBP
- Report
- September 2022
- 136 Pages
Europe
From €3135EUR$3,450USD£2,694GBP
- Report
- September 2022
- 120 Pages
North America
From €3135EUR$3,450USD£2,694GBP
- Report
- August 2021
- 163 Pages
Global
From €4043EUR$4,450USD£3,475GBP
- Report
- June 2025
- 320 Pages
Global
From €4080EUR$4,490USD£3,506GBP
- Report
- June 2025
- 347 Pages
Global
From €4080EUR$4,490USD£3,506GBP
- Report
- March 2025
- 290 Pages
Global
From €4080EUR$4,490USD£3,506GBP
- Report
- December 2020
- 211 Pages
Global
From €4043EUR$4,450USD£3,475GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1817EUR$2,000USD£1,562GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1363EUR$1,500USD£1,171GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1817EUR$2,000USD£1,562GBP
- Drug Pipelines
- April 2025
- 280 Pages
Global
From €2726EUR$3,000USD£2,343GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more